BH3 profiling involves the addition of BH3 peptides derived from BIM, BAD and Harakiri (HRK) to individual AML samples after cell permeabilization, with mitochondrial depolarization monitored using JC-1 dye fluorescence (Extended Data Fig. 9a, top). Here, BCL2L11 is linked to acute myeloid leukemia.